SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 118.44 |
| Enterprise Value ($M) | 165.96 |
| Book Value ($M) | 60.74 |
| Book Value / Share | 0.33 |
| Price / Book | 1.95 |
| NCAV ($M) | 18.18 |
| NCAV / Share | 0.10 |
| Price / NCAV | 6.52 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.47 |
| Return on Assets (ROA) | -0.30 |
| Return on Equity (ROE) | -0.94 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.26 |
| Current Ratio | 4.26 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 261.29 |
| Assets | 303.85 |
| Liabilities | 243.11 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 98.43 |
| Operating Income | -129.92 |
| Net Income | -118.96 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -175.71 |
| Cash from Investing | 142.57 |
| Cash from Financing | 42.12 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 6.70 | -21.55 | |
| 13G | Samlyn Capital, Llc | 5.20 | ||
| 13G/A | Deep Track Capital, LP | 1.07 | -87.59 | |
| 13G/A | Eventide Asset Management, Llc | 3.61 | -29.26 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 270,986 | 1,080,770 | 25.07 | |
| 391,902 | 1,770,442 | 22.14 | |
| 690,181 | 2,105,648 | 32.78 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NAGE – Niagen Bioscience, Inc. | NATR – Nature's Sunshine Products, Inc. |
| NERV – Minerva Neurosciences, Inc. | NLSP – NLS Pharmaceutics AG |
| NRSN – NeuroSense Therapeutics Ltd. |
Financial data and stock pages provided by
Fintel.io